Microbix Biosystems, Inc. (MBX.TO)
0.32
0.00 (0.00%)
CAD |
TSX |
Oct 23, 16:00
Microbix Biosystems Net Income (Quarterly) : -0.8068M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8068M |
| March 31, 2026 | -1.430M |
| December 31, 2025 | -1.167M |
| September 30, 2025 | -1.481M |
| June 30, 2025 | -1.643M |
| March 31, 2025 | 0.0207M |
| December 31, 2024 | 0.857M |
| September 30, 2024 | 0.4403M |
| June 30, 2024 | 0.2467M |
| March 31, 2024 | 0.3777M |
| December 31, 2023 | 2.455M |
| September 30, 2023 | 1.997M |
| June 30, 2023 | -0.7691M |
| March 31, 2023 | 0.0316M |
| December 31, 2022 | -1.299M |
| September 30, 2022 | -0.4641M |
| June 30, 2022 | 0.6385M |
| March 31, 2022 | 0.7335M |
| December 31, 2021 | 0.8808M |
| September 30, 2021 | 0.7789M |
| June 30, 2021 | 1.516M |
| March 31, 2021 | 0.8075M |
| December 31, 2020 | 0.1308M |
| September 30, 2020 | -4.983M |
| June 30, 2020 | -0.4402M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.219M |
| December 31, 2019 | -0.5853M |
| September 30, 2019 | -0.0488M |
| June 30, 2019 | -0.1913M |
| March 31, 2019 | 0.3914M |
| December 31, 2018 | -0.1193M |
| September 30, 2018 | -8.186M |
| June 30, 2018 | 0.001M |
| March 31, 2018 | -0.3425M |
| December 31, 2017 | -0.0941M |
| September 30, 2017 | -1.010M |
| June 30, 2017 | 0.1886M |
| March 31, 2017 | 0.2576M |
| December 31, 2016 | -3.216M |
| September 30, 2016 | 0.8629M |
| June 30, 2016 | 0.048M |
| March 31, 2016 | 0.1759M |
| December 31, 2015 | -0.3384M |
| September 30, 2015 | 0.4031M |
| June 30, 2015 | 0.0822M |
| March 31, 2015 | 0.1268M |
| December 31, 2014 | 0.0019M |
| September 30, 2014 | -0.3516M |
| June 30, 2014 | 0.2106M |
| March 31, 2014 | 0.1939M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Helix BioPharma Corp. | -0.671M |
| Sernova Biotherapeutics, Inc. | -2.529M |
| Hemostemix, Inc. | -0.6324M |
| Medicenna Therapeutics Corp. | -5.082M |
| Spectral Medical, Inc. | 0.331M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 4.059M |
| Total Expenses (Quarterly) | 4.866M |
| EPS Diluted (Quarterly) | -0.0059 |
| Enterprise Value | 43.39M |
| Gross Profit Margin (Quarterly) | 53.92% |
| Profit Margin (Quarterly) | -19.88% |
| Earnings Yield | -11.00% |
| Normalized Earnings Yield | -11.00 |